Bifogade filer
Corline Biomedical Q3 (Review) - Sales growth incoming
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Redeye via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
2025-11-19 08:25:00
Redeye provides an update following Corline’s Q3 2025 report. Sales came in slightly below expectations; however, during the early stages of the Globe launch, some quarterly fluctuations are to be expected, and we see no cause for concern. Based on the report, we have made minor revisions to our estimates, resulting in an updated fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/